Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Greenblatt MB, Tsai JN, Wein MN. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem. 2017;63(2):464-474.

Virmani P, Busam K, Myskowski PL, Yang A, Magro C, Horwitz S. Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab. JAAD Case Rep. 2017;3(4):269-272.

Singh DK, Kollipara RK, Vemireddy V, Yang X-, Sun Y, Regmi N, et al. Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. Cell Rep. 2017;18(4):961-976.

Margolskee E, Saab J, Geyer JT, Aledo A, Mathew S. A Novel Variant t(1;22) Translocation - ins(22;1)(q13;p13p31) - in a Child with Acute Megakaryoblastic Leukemia. Am J Case Rep. 2017;18:422-426.

Ross AE, Hughes RM, Glavaris S, Ghabili K, He P, Anders NM, et al. Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy. Oncotarget. 2017;8(61):104182-104192.

Guerrera F, Renaud S, Tabbo F, Voegeli' A-, Filosso PL, Legrain M, et al. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas. Eur J Cardiothorac Surg. 2017;51(4):680-688.

Linares JF, Amanchy R, Greis K, Diaz-Meco MT, Moscat J. Correction for Linares et al., "Phosphorylation of p62 by cdk1 Controls the Timely Transit of Cells through Mitosis and Tumor Cell Proliferation". Mol Cell Biol. 2017;37(15).

Keesecker S, Saab J, Magro CM, Dokania V, Sclafani AP. Cutaneous Lymphadenoma: A Trichoblastoma with Regressive Inflammatory Changes. Facial Plast Surg. 2017;33(1):109-111.

Westblade LF, Simon MS, Mathison BA, Kirkman LA. Babesia microti: from Mice to Ticks to an Increasing Number of Highly Susceptible Humans. J Clin Microbiol. 2017;55(10):2903-2912.

Yanagida K, Liu CH, Faraco G, Galvani S, Smith HK, Burg N, et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc Natl Acad Sci U S A. 2017;114(17):4531-4536.